About this sample. This page shows the method and structure of the report. It contains no client data; every engagement is prepared for the specific study and indication.
1Overview
An assessment of where a study can realistically recruit. Patient distribution, site and investigator experience and competing trial activity are combined into a site shortlist and a range of enrollment scenarios, each with its assumptions stated.
2Questions this report answers
- ?In which states and regions are eligible patients concentrated?
- ?Which sites and investigators have relevant and recent trial experience?
- ?How many active trials recruit the same population in the same regions?
- ?What enrollment range is realistic under low, base and high assumptions?
3Protocol
The report follows the same documented sequence for every study. Each step produces an output that is kept in the final report.
- 1
Scope and geography
The target population, countries and number of sites are agreed, together with any sites you already plan to use.
Output: Scope statement
- 2
Patient distribution
Disease prevalence is applied to official population estimates by state and age group to show where eligible patients live.
Output: Patient distribution map
- 3
Site and investigator identification
Sites and investigators are identified from trial registry records and profiled by number of trials, recency, phase and sponsor type.
Output: Site long list
- 4
Competitive landscape
Active and recruiting trials that target a similar population in the same regions are identified and mapped.
Output: Competing trial map
- 5
Enrollment scenarios
Low, base and high enrollment ranges are built from site counts and recruitment assumptions, each assumption labelled.
Output: Scenario table
- 6
Shortlist and walkthrough
A prioritised site shortlist is prepared and reviewed with your team.
Output: Report and session
4Report contents
| Section | Title | What it contains |
|---|---|---|
| 1 | Executive summaryRecommended regions, shortlist and the enrollment range. | Recommended regions, shortlist and the enrollment range. |
| 2 | Patient distributionEligible population by state and age group. | Eligible population by state and age group. |
| 3 | Site profilesLong list and shortlist with trial experience. | Long list and shortlist with trial experience. |
| 4 | Investigator profilesInvestigators linked to relevant trials. | Investigators linked to relevant trials. |
| 5 | Competing trialsStudies recruiting a similar population in the same regions. | Studies recruiting a similar population in the same regions. |
| 6 | Enrollment scenariosLow, base and high ranges with assumptions. | Low, base and high ranges with assumptions. |
5Evidence standards
Every figure in the report carries its source, its date and one of four evidence grades, so you can see what is confirmed and what is assumed.
Confirmed
Reported directly by an authoritative source.
Documented
Published or documented, with a clear method.
Estimated
Derived by Clinovia from graded inputs.
Assumed
An explicit assumption, open to review.
6Inputs and deliverables
What we need from you
- Protocol synopsis
- Target number of sites and countries
- Preferred or existing sites, if any
What you receive
- Written report (PDF)
- Site and investigator list (Excel)
- Walkthrough session with your team
Discuss this report for your study
Tell us about the indication and the decision in front of you. A pilot on a single study is a good place to start.
Other intelligence reports